Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Secondary Hyperparathyroidism-Chronic Kidney Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT05836220
What this trial is testing

Parathyroid Hormone (PTH) Attenuation Trial in Hemodialysis-2

Who this might be right for
Secondary HyperparathyroidismEnd Stage Kidney Disease
Pathalys Pharma 412
Not applicableStudy completedNCT01073462
What this trial is testing

Study to Evaluate the Effect of Intravenous (IV) Paricalcitol (Zemplar) on Cardiac Morbidity in Patients With Chronic Kidney Disease (CKD) Stage 5 Over 2 Years

Who this might be right for
Secondary HyperparathyroidismChronic Kidney Disease Stage VCardiac Morbidity
AbbVie (prior sponsor, Abbott) 67
Large-scale testing (Phase 3)UnknownNCT01479088
What this trial is testing

Cinacalcet in Paediatric Secondary Hyperparathyroidism (SHPT) Due to Chronic Kidney Disease (CKD)

Who this might be right for
Secondary Hyperparathyroidism
ENRICO VERRINA 30
Not applicableLooking for participantsNCT07171216
What this trial is testing

The Effect of REgulation of PArathyroId hoRmone in Patients With Chronic Kidney Disease to Investigate the Change in Bone Mineral Density

Who this might be right for
Chronic Kidney Disease Mineral and Bone Disorder
Herlev Hospital 70
Testing effectiveness (Phase 2)WithdrawnNCT01453634
What this trial is testing

Four Week, Pharmacodynamic/Pharmacokinetic, Efficacy, and Safety Study of Lunacalcipol (CTA018)

Who this might be right for
Stage 5 Chronic Kidney Disease (CKD)Secondary Hyperparathyroidism (SHPT)Hemodialysis (HD)
OPKO Health, Inc.
Testing effectiveness (Phase 2)UnknownNCT06398002
What this trial is testing

The Effect of Increasing Dialysate Calcium on T50 in Subjects With Secondary Hyperparathyroidism and ESKD

Who this might be right for
Secondary HyperparathyroidismEnd-stage Kidney Disease
Iain Bressendorff 48
Post-approval studies (Phase 4)Study completedNCT00891813
What this trial is testing

Effectiveness and Safety of IV Zemplar in Patients on Hemodialysis and With Secondary Hyperparathyroidism Using iPTH/100 as Initial Dose

Who this might be right for
Secondary HyperparathyroidismRenal Insufficiency, ChronicParathyroid Hormone+2 more
Abbott 100
Not applicableLooking for participantsNCT07141043
What this trial is testing

Assessment of Mineral and Bone Disorders in Kidney Transplant Recipients

Who this might be right for
HemodyalysisKidney TansplantOsteoporosis+1 more
Grigore T. Popa University of Medicine and Pharmacy 180
Post-approval studies (Phase 4)Study completedNCT01115543
What this trial is testing

Efficacy and Safety of Alfacalcidol Compared to Calcitriol for Treatment of Secondary Hyperparathyroidism

Who this might be right for
Secondary HyperparathyroidismEnd Stage Renal Disease
Mahidol University 32
Not applicableEnded earlyNCT00374712
What this trial is testing

Klotho Gene Polymorphism in Dialyzed Patients With Hyperphosphatemia

Who this might be right for
Chronic Kidney DiseaseEnd Stage Renal DiseaseHyperphosphatemia+1 more
Assistance Publique - Hôpitaux de Paris 40
Testing effectiveness (Phase 2)Study completedNCT01414114
What this trial is testing

Etelcalcetide to Treat Secondary Hyperparathyroidism in Hemodialysis Patients With Chronic Kidney Disease-Mineral and Bone Disorder

Who this might be right for
Secondary Hyperparathyroidism
KAI Pharmaceuticals 37
Post-approval studies (Phase 4)Study completedNCT00463021
What this trial is testing

Determine Dosing of Hectorol® Capsules When Converting From Zemplar® Injection

Who this might be right for
Secondary Hyperparathyroidism
Genzyme, a Sanofi Company 36
Post-approval studies (Phase 4)Study completedNCT00110890
What this trial is testing

A Research Study for Patients With End-Stage Renal Disease (ESRD)

Who this might be right for
End Stage Renal Disease
Amgen 552
Not applicableStudy completedNCT00785629
What this trial is testing

A Double Blind Randomized Placebo Trial of Maintenance of Normal Serum Phosphorus in CKD

Who this might be right for
Chronic Kidney Disease
Denver Nephrologists, P.C. 148
Post-approval studies (Phase 4)UnknownNCT05720273
What this trial is testing

Neutrophil Gelatinase-associated Lipocalin VS Vascular Calcification in Maintenance Hemodialysis Patients

Who this might be right for
Chronic Kidney Disease-Mineral and Bone Disorder
Xiaoyan Jia 80
Post-approval studies (Phase 4)Study completedNCT01506947
What this trial is testing

A Pilot Clinical Study Evaluating the Effect of Parathyroid Hormone (PTH) Lowering On Erythropoietin Consumption in Calcitriol-Resistant Patients

Who this might be right for
Moderate to Severe Secondary HyperparathyroidismStage 5 Chronic Kidney Diseases
AbbVie (prior sponsor, Abbott) 65
Testing effectiveness (Phase 2)Study completedNCT00508885
What this trial is testing

The Effect of Oral Niacinamide on Plasma Phosphorus Levels in Peritoneal Dialysis Patients

Who this might be right for
Hyperphosphatemia
Washington University School of Medicine 17
Testing effectiveness (Phase 2)Looking for participantsNCT06906874
What this trial is testing

Activated Charcoal Use in Chronic Kidney Disease Patients

Who this might be right for
End Stage Renal Disease (ESRD)CKD 5D, HemodialysisCKD-MBD - Chronic Kidney Disease Mineral and Bone Disorder
Mansoura University 40
Not applicableLooking for participantsNCT07368946
What this trial is testing

Phosphate Assessment in Chronic Kidney Disease Patients Study

Who this might be right for
Chronic Kidney Disease (Stage 3-4)Chronic Kidney Disease Mineral and Bone Disorder
University of Texas Southwestern Medical Center 60
Not applicableStudy completedNCT04019379
What this trial is testing

Calcium and Phosphorus Whole-Body Balance and Kinetics in Patients With Moderate Chronic Kidney Disease

Who this might be right for
Phosphorus and Calcium DisordersChronic Kidney Disease Mineral and Bone DisorderChronic Kidney Diseases
University of Minnesota 3
Next Page